San Diego-based AnaptysBio, a developer of antibody-based drugs, has placed a stake in the ground to go public, filing IPO paperwork Wednesday. The 10-year-old firm recently raised a $40 million Series D round of funding from crossover investors, setting itself up for a run at the public markets. Crossover investors have helped fuel the three-year … Continue reading “Antibody Maker AnaptysBio Joins IPO Queue With $86M In Its Sights”
Category: New York
Biogen Pays $60M to Take on Celgene With a Rival Autoimmune Drug
It’s unclear if Biogen was one of the unnamed bidders that lost out on Receptos a few months ago. But a deal the Cambridge-based company made this morning for a drug that would directly compete with Receptos sure makes it seem that way. Biogen (NASDAQ: [[ticker:BIIB]]) this morning paid $60 million up front for worldwide … Continue reading “Biogen Pays $60M to Take on Celgene With a Rival Autoimmune Drug”
Fresco News Obtains $1,200,000 Seed Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=51902d54-765c-4e41-8e0b-64e598b2b5fc Date 9/9/2015 Company Name Fresco News Mailing Address 120 E 23rd St. New York, NY 10010 USA Company Description Browse breaking news photos and videos from people around the world. See every angle of the story. Report the news as you experience it. Take assignments and get features by news outlets … Continue reading “Fresco News Obtains $1,200,000 Seed Round”
Routehappy Receives $3,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=78606166-a351-470c-9c9e-6d8dba952927 Date 9/9/2015 Company Name Routehappy Mailing Address 175 Varick Street 4th Floor New York, NY 10014 USA Company Description Routehappy is on a mission to help you find the best flights every time you fly. We want to take the guesswork out of flight search and help you have better experiences … Continue reading “Routehappy Receives $3,000,000 New Funding”
Electric Objects Garners $4,999,994 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=82481125-6f0b-4be0-a558-e0adbf24bffd Date 9/9/2015 Company Name Electric Objects Mailing Address 295 E. 8th Street New York, NY 10009 USA Company Description The Internet is full of beautiful objects, and we’re building a screen that lives up to them. We’re going to put the Internet on your wall. Website http://www.electricobjects.com Transaction Type Venture Equity … Continue reading “Electric Objects Garners $4,999,994 Series A Round”
Trading Ticket Receives $4,000,000 Seed Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5f82ae7b-e569-4704-ac9b-e1d241112fed Date 9/9/2015 Company Name Trading Ticket Mailing Address Undisclosed New York, NY 10021 USA Company Description Trading Ticket, a startup based out of New York, wants to develop a suite of products that will help consumers become more active, and proactive, investors. Website http://www.trade.it Transaction Type Venture Equity Transaction Amount $4,000,000 … Continue reading “Trading Ticket Receives $4,000,000 Seed Financing Round”
How to Succeed in the Second Digital Era
Blockbuster. Borders. The U.S. Postal Service. These once-dominant entities, and many more, have all been victims of disruptive tech. Although it’s too early to sound the death knell for taxis, it’s also too late to say that ridesharing companies like Uber and Lyft are a flash in the pan. The disruptive change they represent is … Continue reading “How to Succeed in the Second Digital Era”
NY Genome Center Names Cheryl Moore New Prez
Cheryl Moore, currently the executive vice president and COO of the Howard Hughes Medical Institute, has been named the president and COO of the New York Genome Center. Moore, who also had an executive stint at La Jolla, CA’s Sanford Burnham Prebys Medical Discovery Institute, will begin working at the NYGC in January. She’ll run … Continue reading “NY Genome Center Names Cheryl Moore New Prez”
Student Loan Marketplace CommonBond Raises $35M, Plans New Hires
A bit more cash is going into the pockets of yet another New York-based fintech company. With $35 million more funding announced Tuesday, CommonBond plans to grow its staff, develop its technology, and to scale up its operations. “We are about 35 people right now; we’d like to be 60 people in the next six months,” … Continue reading “Student Loan Marketplace CommonBond Raises $35M, Plans New Hires”
Inclusion in Tech Entrepreneurship: Meritocracy or Myth?
We’ve been hearing a lot about how the high-tech industry has been working to recruit more underrepresented minorities and women into its ranks, without much early success. Less than 2 percent of the employees at Facebook, Google, and Twitter are African-American, according to the companies’ Equal Employment Opportunity reports for 2014, released earlier this year. … Continue reading “Inclusion in Tech Entrepreneurship: Meritocracy or Myth?”
Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round
Crossover investors—institutions that back both public and private companies—have been piling money into biotechs over the past few years. Today you can add Selecta Biosciences to the list of crossover-cash recipients, and pencil the Watertown, MA-based company as a future IPO candidate to boot. Selecta, a developer of nanoparticle technology, has raised a $38 million … Continue reading “Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round”
9 Frothy Tech Sectors of 2015: Food Delivery, Fintech, Drones & More
There’s a point at which a technology market or sector feels overhyped and saturated. Sometimes it’s when the first $1 billion valuation is announced—or when venture capital starts flowing so freely that it seems due diligence is an afterthought. And it’s definitely when media start calling tech businesses “Uber for (fill in the blank).” In … Continue reading “9 Frothy Tech Sectors of 2015: Food Delivery, Fintech, Drones & More”
CommonBond Obtains $35,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e279a0fc-d74c-4d21-85c4-8f43decd168d Date 9/8/2015 Company Name CommonBond Mailing Address 120 Walker St. 4th Floor New York, NY 10013 USA Company Description CommonBond lowers the cost of higher education in the U.S. Our platform connects student borrowers and alumni investors to save students money on their loans and allow alumni to earn a financial … Continue reading “CommonBond Obtains $35,000,000 Series B Round”
FeeX Lands $2,750,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ea3664a0-8b5b-4682-9ca8-c2c1eae2ca72 Date 9/8/2015 Company Name FeeX Mailing Address 205 E 42nd Street 17th Floor New York, NY 10017 USA Company Description The financial industry is built on an asymmetry of information that causes us to pay high fees for average performance. What’s worse, most of us don’t even notice. As the Robin … Continue reading “FeeX Lands $2,750,000 New Funding”
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More
What summer doldrums? It’s still not even Labor Day, yet the deals are already coming fast and furious. So fire up the grill and read on for some Series A rounds, crossover investments, data readouts, option-to-buy deals and more. —As Xconomy reported this week, a stealthy Cambridge, MA-based startup called X4 Pharmaceuticals raised a $37.5 … Continue reading “East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More”
With New CEO, Seattle’s Faraday Pharma Aims to Exploit Ikaria Roots
[Updated 9/3/15, 11:30 am. See below.] Tiny Faraday Pharmaceuticals of Seattle launched last year to try what its predecessor Ikaria couldn’t do: Turn the cutting-edge research of founder Mark Roth, a MacArthur Foundation “genius” award winner, into a medical product. Now Faraday, which emerged from stealth and announced a round of funding last year but … Continue reading “With New CEO, Seattle’s Faraday Pharma Aims to Exploit Ikaria Roots”
Content Marketing Software Dev NewsCred Gets $42M, Plans Hiring Surge
NewsCred announced Wednesday it raised $42 million, just about doubling its total funding, for its content marketing management software at a time when marketers continue a pell-mell frenzy to keep the audience’s attention. Frankly, it is getting harder to make content from brands stick with the increasingly jaded and disinterested masses who change their media … Continue reading “Content Marketing Software Dev NewsCred Gets $42M, Plans Hiring Surge”
Shire Sends Hemophilia Gene Editing Prospects Back to Sangamo
There is no single race in gene therapy, or gene editing for that matter, more competitive than the one between companies trying to create treatments for hemophilia. And if one of its entrants, Sangamo Biosciences, is going to come out on top, it’ll likely have to do it without the help of Shire. Sangamo Biosciences … Continue reading “Shire Sends Hemophilia Gene Editing Prospects Back to Sangamo”
NewsCred Lands $42,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d89e837d-b089-46cd-8c62-0e55873e92ff Date 9/2/2015 Company Name NewsCred Mailing Address 386 Park Ave S. 6th Floor New York, NY 10016 USA Company Description NewsCred is a New York based media company focused on creating a single platform for the world’s news. Website http://www.newscred.com Transaction Type Venture Equity Transaction Amount $42,000,000 Transaction Round Undisclosed Proceeds … Continue reading “NewsCred Lands $42,000,000 New Financing Round”
TransferWise, Backed by Branson and Others, Preps U.S. Expansion
Looking to take some of the fees out of sending money overseas, TransferWise is firing up its New York team for its U.S. expansion. The London-based company says it is a lower-cost option—compared with banks and other incumbent money transfer businesses—that uses a software platform to pair transactions that are going in opposite directions between … Continue reading “TransferWise, Backed by Branson and Others, Preps U.S. Expansion”
At Summer’s End, Can Crossover Winds Stay At Biotech’s Back?
For certain parts of the population, “summer” is a verb, and in the U.S., one does it until Labor Day. One more week, then, before sunburned financial types return to their desks and biotech IPO hopefuls hit the road to plead their cases. Whether August’s market volatility continues its stomach-churning ways or recedes in September’s … Continue reading “At Summer’s End, Can Crossover Winds Stay At Biotech’s Back?”
Code Climate Lands $2,039,986 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=22986b02-e7b1-44fc-9d8f-b36b0775b049 Date 9/1/2015 Company Name Code Climate Mailing Address 77 Second Ave. New York, NY 10003 USA Company Description Code Climate consolidates the results from a suite of static analysis tools into a single, real-time report, giving your team the information it needs to identify hotspots, evaluate new approaches, and improve code … Continue reading “Code Climate Lands $2,039,986 New Financing”
5 Questions to Ask Before Investing in People or Technology
Congratulations. Your startup made it through its first challenging years, and you’re seeing positive returns. But, there’s always room to grow. Is it time to hire more salespeople, or should you invest in customer relationship management (CRM), productivity software, or another technology that can improve your business? The choice between putting money into technology or … Continue reading “5 Questions to Ask Before Investing in People or Technology”
Bristol-Myers Makes $150M Bet on Promedior, Fibrosis Drug
New drugs for fibrosis, an internal, often deadly type of scarring, have become the centerpiece of a number of biotech deals over the past few years. The latest just crossed the wires this morning, as Bristol-Myers Squibb has just nabbed an option to buy Promedior, of Lexington, MA. Bristol-Myers (NYSE: [[ticker:BMY]]) is paying $150 million … Continue reading “Bristol-Myers Makes $150M Bet on Promedior, Fibrosis Drug”
With $229M Deal, Amicus Gets a New Drug And Perhaps a Voucher
Just how far has Amicus Therapeutics come in two years? In 2013, the Cranbury, NJ-based company was reeling from a trial failure and restructuring to conserve cash. Now, it’s eyeing its first drug approval and buying a startup in a nine-figure deal. Amicus (NASDAQ: [[ticker:FOLD]]) this morning is announcing the acquisition of Durham, NC-based Scioderm. … Continue reading “With $229M Deal, Amicus Gets a New Drug And Perhaps a Voucher”
In New York, Rgenix Rises From Rockefeller and Takes Aim at Cancer
If you tried to count on one hand the number of New York City biotech startups to get a substantial funding round this year, you’d probably have a few fingers left over. A stealthy startup out of Rockefeller University named Rgenix is one of the lucky few to score a significant haul, and today it’s … Continue reading “In New York, Rgenix Rises From Rockefeller and Takes Aim at Cancer”
AOL Acquires Kanvas for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=832d2e95-b216-424f-833a-872a25e82d0e Date 8/31/2015 Company Name Kanvas Mailing Address 875 Ave Of The Americas New York, NY 10001 USA Company Description Kanvas is a new way to make social photo stories. Make a track for vacations, hanging out, or just keeping up with friends and family around the world. Website http://www.getkanvas.com Transaction Type … Continue reading “AOL Acquires Kanvas for Undisclosed Sum”
FlexTech Alliance To Manage $75M Defense Institute for Tech Manufacturing
California research consortium FlexTech Alliance announced today it has landed a $75 million U.S. Department of Defense contract that makes it the organizational hub for a sweeping government effort to advance American manufacturing capabilities for flexible products like clothing that are enhanced with electronic sensors and processing power. The Defense Department will funnel research contracts … Continue reading “FlexTech Alliance To Manage $75M Defense Institute for Tech Manufacturing”
Women, Get Off the Sidelines and Invest
In my travels across the country, I meet successful women with the means and motivation to make a difference in our communities—and in our world. We don’t think twice about writing a check to a worthy foundation, buying a table at a charity gala, or volunteering on a committee. We know the “rubber chicken” circuit … Continue reading “Women, Get Off the Sidelines and Invest”
Recruitment Software Developer Greenhouse Grabs $35M
[Updated, 12:30 pm with comments from CEO Daniel Chait.] New York-based Greenhouse Software announced Friday it raised $35 million in a Series C round led by Thrive Capital, with returning investors Benchmark, Groupe Arnault, and The Social+Capital Partnership participating. Greenhouse developed a hiring software platform—which includes getting jobs listed across the Web and social media, scheduling interviews, and … Continue reading “Recruitment Software Developer Greenhouse Grabs $35M”
East Coast Biotech Roundup: StartUp Health, Constellation, Highline & More
Nothing like a little drama to end your summer, right? Market volatility dragged biotech down this week, and then lifted it back up—at least as of Friday morning. But if you’re confused by the tumult and looking for some distractions, we’ve got plenty of them below. Read on for details of some biotech and digital … Continue reading “East Coast Biotech Roundup: StartUp Health, Constellation, Highline & More”
Our Plan for Reinventing Alzheimer’s Disease R&D at UC San Diego
When the late Dr. Leon Thal, renowned neurologist and chairman of the Neurosciences Department at the UC San Diego School of Medicine, first imagined a research network able to conduct clinical trials of new therapies for Alzheimer’s disease, it was an idea ahead of its time. The degenerative condition was poorly understood, with no existing … Continue reading “Our Plan for Reinventing Alzheimer’s Disease R&D at UC San Diego”
Sundar Garners $1,075,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2e3abbf6-d5e4-49b7-9e9d-346ca0a75185 Date 8/28/2015 Company Name Sundar Mailing Address 325 Canal St. New York, NY 10013 USA Company Description Sundar provides a curated B2B marketplace for apparel and accessories sourcing, by matching suppliers with creative professionals. Website http://www.sundar.io Transaction Type Debt Transaction Amount $1,075,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not … Continue reading “Sundar Garners $1,075,000 New Round”
Hyper Obtains $1,100,000 Seed Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f8de1054-278d-4224-ba72-be1b22d7e1f4 Date 8/28/2015 Company Name Hyper Mailing Address Undisclosed New York, NY 10022 USA Company Description Hyper is a new video magazine for iPad with a clear less is more approach. With daily editions of only 6 to 12 hand-picked videos and a beautiful, minimalist design, Hyper simply provides the best of … Continue reading “Hyper Obtains $1,100,000 Seed Round”
7Park Data Receives $3,000,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f6f20a5f-8651-4aec-ad31-e3b6e0c249ba Date 8/28/2015 Company Name 7Park Data Mailing Address 275 Madison Ave. New York, NY 10016 USA Company Description 7Park Data’s team shares a passion and belief that innovation, data and technology collectively address the evolving information requirements of our clients. Website http://www.7parkdata.com Transaction Type Venture Equity Transaction Amount $3,000,000 Transaction Round … Continue reading “7Park Data Receives $3,000,000 Series A Financing Round”
MimiVax Receives $1,550,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=04ddc50d-6846-47da-a096-03c0ba36ece3 Date 8/28/2015 Company Name MimiVax Mailing Address Elm & Carlton Streets MRC Buffalo, NY 14263 USA Company Description MimiVax is commercializing intellectual property developed at Roswell Park Cancer Institute (RPCI) through bench to bedside clinical translation. We are developing immunotherapeutic vaccines and targeted therapies for cancer treatment. SurVaxM is our lead … Continue reading “MimiVax Receives $1,550,000 New Round”
With FDA OK, Amgen’s Heart Drug Faces Rival (And Health Budgets)
[Updated and corrected 8/27/15, 7:28pm, see below.] The new race to fight cholesterol is on. For the second time in a month, the U.S. Food and Drug Administration has approved a drug for people with dangerous levels of cholesterol who aren’t getting enough help from statins, which have long been among the world’s most prescribed … Continue reading “With FDA OK, Amgen’s Heart Drug Faces Rival (And Health Budgets)”
Yahoo Tries to Get NY App Developers Hyped About Its Push into Mobile
For the first time ever, Yahoo brought its Mobile Developer Conference to New York—talking up its plans to more firmly embrace mobile and trying to coax more app developers to work with its software and services. The two-day conference started with a hackathon and then wrapped Wednesday, bringing out some 500 attendees from New York’s … Continue reading “Yahoo Tries to Get NY App Developers Hyped About Its Push into Mobile”
BizSlate Lands $3,500,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=991d5a4c-92a7-41c8-ba5b-c3c57a26a6cb Date 8/27/2015 Company Name BizSlate Mailing Address 261 Madison Avenue New York, NY 10016 USA Company Description BizSlate is a Software-as-a-Service Enterprise Resource Planning (ERP) system that helps small and medium sized businesses (SMBs) overcome supply chain and operational issues they face while running their business. BizSlate is the initial product … Continue reading “BizSlate Lands $3,500,000 New Round”
Augury Garners $7,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=06220ee2-1ec6-42fd-a3d2-737cf15f76f1 Date 8/26/2015 Company Name Augury Mailing Address 110 Fifth Ave. 5th Floor New York, NY 10011 USA Company Description We are bringing Predictive Maintenance to new markets. By listening to a machine we can tell if it is working properly, has a malfunction and even predict future failures. Website http://www.augury.com Transaction … Continue reading “Augury Garners $7,000,000 Series A Financing”
KeyMe Secures $5,375,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=402adae5-9de3-414c-969b-74f487f538bc Date 8/26/2015 Company Name KeyMe Mailing Address 45-50 30th Street Long Island City, NY 11101 USA Company Description Choose from a wide selection of key designs including sports, designer, college, and a bottle opener key. Just scan your key with the KeyMe app and choose the design. We’ll take care of … Continue reading “KeyMe Secures $5,375,000 New Funding Round”
EDF Renewable Energy Acquires OwnEnergy for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e33d8836-cfe2-439f-a057-feaac2b80fbd Date 8/26/2015 Company Name OwnEnergy Mailing Address 45 Main Street Brooklyn, NY 11201 USA Company Description OwnEnergy partners with landowners to develop renewable energy projects, with an initial focus on 10 – 80 MW wind energy projects. Our partners take an active role in the development and installation process in return … Continue reading “EDF Renewable Energy Acquires OwnEnergy for Undisclosed Sum”
Biz2Credit Preps for More Partnerships & Revenue in Small Biz Lending
The demand for small-business lending services is an ever-growing part of the financial world. New York-based Biz2Credit is positioning itself to keep riding this trend. Like others in this sector, co-founder and CEO Rohit Arora says Biz2Credit exists to address gaps in lending when businesses qualify for loans but have difficulty finding the right financing. Biz2Credit’s … Continue reading “Biz2Credit Preps for More Partnerships & Revenue in Small Biz Lending”
Greenhouse Software Obtains $35,000,000 Series C Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=027ec34d-a986-4af2-b9bd-df7b29150776 Date 8/25/2015 Company Name Greenhouse Software Mailing Address 455 Broadway 3rd Floor New York, NY 10013 USA Company Description I launched Greenhouse with a single goal: Make companies great at hiring. The response has been phenomenal. As more and more organizations have moved to Greenhouse, insurmountable recruiting bottlenecks have vanished, and … Continue reading “Greenhouse Software Obtains $35,000,000 Series C Financing Round”
New CEO and $80M Later, Syndax Looks Prepped for Second IPO Try
If Syndax Pharmaceuticals’ latest financing is any indication, the Waltham, MA-based firm looks to have another shot at an initial public offering in mind. Syndax has closed a $80 million Series C financing round from a large swath of “crossover” investors that back both public and private companies. Several of the firms in Syndax’s financing … Continue reading “New CEO and $80M Later, Syndax Looks Prepped for Second IPO Try”
CB Insights Evolves with $1.15M from the National Science Foundation
[UPDATED 8/26/15. See below.] Taking in its first-ever outside funding, CB Insights is growing its ranks, working on its software, and kicking off a new service called CB Insights for Sales. New York-based venture data firm CB Insights launched in 2010, to be what co-founder and CEO Anand Sanwal called a “Bloomberg for private markets.” The … Continue reading “CB Insights Evolves with $1.15M from the National Science Foundation”
Versant Walks Biotech “High Line” With a New Manhattan Incubator
Versant Ventures is about to launch its latest biotech incubator. And it’s picked the emerging New York life sciences scene as its home. This morning, Versant, the San Francisco Bay Area VC firm, is announcing the formation of what’s being called “Highline Therapeutics.” Named after the elevated walkway and park that runs along the lower … Continue reading “Versant Walks Biotech “High Line” With a New Manhattan Incubator”
In New York, A Digital Health ‘Mashup’ Builds A Startup Army
[Corrected 8/24/15, 12:40 pm. See below.] The booming field of digital health means different things to different people. Even the president of StartUp Health, a New York-based firm that wants to help build 1,000 digital health startups—yes, literally—acknowledges his company is a little tough to define. “We’ve had a challenge with how people bin us … Continue reading “In New York, A Digital Health ‘Mashup’ Builds A Startup Army”
Crowdability Obtains $1,602,516 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cafc9e66-f83c-4fac-9706-d1998c22f9fd Date 8/24/2015 Company Name Crowdability Mailing Address 229 West 28th Street 12th Floor New York, NY 10001 USA Company Description For years, wealthy investors have had the right to invest in high-growth companies at their earliest stages. In some of the boldest changes to U.S. securities laws in nearly 100 years, … Continue reading “Crowdability Obtains $1,602,516 New Financing Round”
East Coast Biotech Roundup: WaVe, Shkreli, Intarcia & More
The top story in biotech this week was the FDA’s approval of the first drug meant to boost women’s sex drive. The controversial flibanserin (Addyi) had been rejected in the past by the agency, and even post-approval faces questions about potential safety issues, effectiveness, and potential market reach. Nonetheless, Valeant Pharmaceuticals quickly snapped up the … Continue reading “East Coast Biotech Roundup: WaVe, Shkreli, Intarcia & More”